Product Information

SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB is a generic product labeled by Prasco Laboratories, priced at $0.5254 per EA under NDC 66993018802. Its NADAC has been published 250 times since Feb 9, 2022.

FDA first approved this application on Dec 30, 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB

spironolactone and hydrochlorothiazide
$0.5254per EA

Strength

25; 25 mg/1; mg/1

NDC

66993018802

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA012616

FDA Approved

12/30/1982

TE Code

AB

On Market Since

11/29/2021

Pharmacological Classes

Aldosterone Antagonist
Aldosterone Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB has been published 250 times since Feb 9, 2022, and over the history we have for it it has declined 13.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5254 per EA
All-time high$0.6867 (May 11, 2022)
All-time low$0.3906 (Nov 20, 2024)
52-week high$0.5415
52-week low$0.4833
Median price$0.5771
Average price$0.5762
Largest weekly change+37.7% (Aug 21, 2024)
Weeks tracked250
Tracking sinceFeb 9, 2022

Price History

1W

+3.8%

1M

+8.7%

3M

+5.9%

6M

-1.7%

1Y

-6.5%

3Y

-14.5%

5Y

N/A

All

-13.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

The current National Average Drug Acquisition Cost (NADAC) for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB, manufactured by Prasco Laboratories, is $0.5254 per EA (NDC 66993018802), effective Nov 18, 2026.

How has the price of SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB changed over time?

Over the history we have for it, the NADAC for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB has declined 13.6%. It has been tracked across 250 weekly CMS publications since Feb 9, 2022.

What are the highest and lowest recorded NADAC prices for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

Since Feb 9, 2022, the NADAC for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB has ranged from a low of $0.3906 (Nov 20, 2024) to a high of $0.6867 (May 11, 2022), with a median of $0.5771 per EA.

Are there cheaper alternatives to SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB (NDC 66993018802) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.